LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,304 | +89.8% | 81,930 | +298.7% | 0.00% | – |
| Q2 2023 | $47,055 | -55.5% | 20,548 | -52.8% | 0.00% | – |
| Q1 2023 | $105,761 | +219.5% | 43,523 | +151.1% | 0.00% | – |
| Q4 2022 | $33,102 | -60.1% | 17,331 | -49.8% | 0.00% | – |
| Q3 2022 | $83,000 | +102.4% | 34,541 | +75.1% | 0.00% | – |
| Q1 2022 | $41,000 | -78.5% | 19,723 | -59.3% | 0.00% | – |
| Q4 2021 | $191,000 | -27.7% | 48,467 | -11.6% | 0.00% | – |
| Q3 2021 | $264,000 | +60.0% | 54,820 | +52.7% | 0.00% | – |
| Q2 2021 | $165,000 | +24.1% | 35,911 | +58.4% | 0.00% | – |
| Q1 2021 | $133,000 | +682.4% | 22,676 | +88.8% | 0.00% | – |
| Q3 2020 | $17,000 | -52.8% | 12,011 | -33.8% | 0.00% | – |
| Q2 2020 | $36,000 | -37.9% | 18,147 | +29.7% | 0.00% | – |
| Q4 2019 | $58,000 | -68.5% | 13,991 | -77.1% | 0.00% | – |
| Q3 2019 | $184,000 | – | 61,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |